Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix(®)) to Guide Treatment of Patients with Depression and/or Anxiety.

Najafzadeh M, Garces JA, Maciel A

Open source

DOI
10.1007/s40273-017-0587-0
Published
2017 Dec
Container
PharmacoEconomics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40273-017-0587-0,
  title = {Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix(®)) to Guide Treatment of Patients with Depression and/or Anxiety.},
  author = {Najafzadeh M and Garces JA and Maciel A},
  year = {2017},
  journal = {PharmacoEconomics},
  doi = {10.1007/s40273-017-0587-0},
  url = {https://doi.org/10.1007/s40273-017-0587-0}
}

RIS

TY  - JOUR
TI  - Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix(®)) to Guide Treatment of Patients with Depression and/or Anxiety.
AU  - Najafzadeh M
AU  - Garces JA
AU  - Maciel A
PY  - 2017
JO  - PharmacoEconomics
DO  - 10.1007/s40273-017-0587-0
UR  - https://doi.org/10.1007/s40273-017-0587-0
ER  - 

APA

M, N., JA, G., & A, M. (2017). Economic Evaluation of Implementing a Novel Pharmacogenomic Test (IDgenetix(®)) to Guide Treatment of Patients with Depression and/or Anxiety.. PharmacoEconomics. https://doi.org/10.1007/s40273-017-0587-0

Source records